Riskpilot← Back to searchSign inGet full accessEPIMEDIS AS
ASActiveOrg 926549251Havnabakken 18, 0874 OsloRetail sale of other food · NACE 4727Est. 20210 employees
Revenue 2024
NOK 2,9M
+122% vs 2023
EBITDA margin
12.3%
+497% vs 2023
Equity ratio
66.9%
Financial strength
Net profit 2024
NOK 282K
+519% vs 2023
| Revenue | NOK 2,9M | +122% |
| EBITDA | NOK 359K | +497% |
| Net profit | NOK 282K | +519% |
| Total assets | NOK 776K | +139% |
| Equity | NOK 519K | +120% |
| Employees | 0 | — |
Legal name
EPIMEDIS AS
Org number
926549251
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
18. februar 2021
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Fremstilling/salg av kosttilskudd og helseprodukter og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Havnabakken 18, 0874 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 825 | 1 969 | 1 311 | 2 914 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | 79 | 155 | 60 | 359 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 79 | 155 | 60 | 359 |
| Net financials | 1 | −30 | −0 | 2 |
| Profit before tax | 80 | 125 | 60 | 361 |
| Tax | 18 | 28 | 14 | 80 |
| Net profit | 62 | 97 | 46 | 282 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 220 | 226 | 324 | 776 |
| Equity | 92 | 190 | 235 | 519 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 127 | 36 | 88 | 257 |
| Total debt | 127 | 36 | 88 | 257 |
EBITDA margin
12.3%
This company
15.8%
Market median
-22% vs market
20212024
Equity ratio
66.9%
This company
38.2%
Market median
+75% vs market
20212024
Return on equity
54.3%
This company
18.4%
Market median
+195% vs market
20212024
Net profit margin
9.7%
This company
8.1%
Market median
+20% vs market
20212024
Asset turnover
3.76×
This company
1.12×
Market median
+236% vs market
20212024
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
VS Chief Executive Officer | Chief Executive Officer | 2021 |
KK Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EPIMEDIS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Victor Selinger Aas | Chief Executive Officer | 0 companies |
| Knut Kristian Fondal Aas | Chief Executive Officer | 0 companies |
| Trond Ødegård | Chairman | 0 companies |
| Sverre Paaske | Board of Directors | 0 companies |